|
1
|
Perez CA, Fu A, Onishko H, Hallahan DE and
Geng L: Radiation induces an antitumour immune response to mouse
melanoma. Int J Radiat Biol. 85:1126–1136. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chakravarty PK, Guha C, Alfieri A, et al:
Flt3L therapy following localized tumor irradiation generates
long-term protective immune response in metastatic lung cancer: its
implication in designing a vaccination strategy. Oncology.
70:245–254. 2006. View Article : Google Scholar
|
|
3
|
Nakajima K, Yanagawa T, Watanabe H and
Takagishi K: Hyperthermia reduces migration of osteosarcoma by
suppression of autocrine motility factor. Oncol Rep. 28:1953–1958.
2012.PubMed/NCBI
|
|
4
|
Weiss EM, Frey B, Rodel F, et al: Ex vivo-
and in vivo-induced dead tumor cells as modulators of antitumor
responses. Ann NY Acad Sci. 1209:109–117. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Das A and Ali N: Vaccine prospects of
killed but metabolically active Leishmania against visceral
leishmaniasis. Expert Rev Vaccines. 11:783–785. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dols A, Smith JW II, Meijer SL, et al:
Vaccination of women with metastatic breast cancer, using a
costimulatory gene (CD80)-modified, HLA-A2-matched, allogeneic,
breast cancer cell line: clinical and immunological results. Hum
Gene Ther. 14:1117–1123. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Riedl K, Baratelli F, Batra RK, et al:
Overexpression of CCL-21/secondary lymphoid tissue chemokine in
human dendritic cells augments chemotactic activities for
lymphocytes and antigen presenting cells. Mol Cancer. 2:352003.
View Article : Google Scholar
|
|
8
|
Li B, VanRoey M, Wang C, Chen TH, Korman A
and Jooss K: Anti-programmed death-1 synergizes with granulocyte
macrophage colony-stimulating factor-secreting tumor cell
immunotherapy providing therapeutic benefit to mice with
established tumors. Clin Cancer Res. 15:1623–1634. 2009. View Article : Google Scholar
|
|
9
|
van Elsas A, Hurwitz AA and Allison JP:
Combination immunotherapy of B16 melanoma using anti-cytotoxic T
lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage
colony-stimulating factor (GM-CSF)-producing vaccines induces
rejection of subcutaneous and metastatic tumors accompanied by
autoimmune depigmentation. J Exp Med. 190:355–366. 1999.
|
|
10
|
van den Eertwegh AJ, Versluis J, van den
Berg HP, et al: Combined immunotherapy with granulocyte-macrophage
colony-stimulating factor-transduced allogeneic prostate cancer
cells and ipilimumab in patients with metastatic
castration-resistant prostate cancer: a phase 1 dose-escalation
trial. Lancet Oncol. 13:509–517. 2012.
|
|
11
|
Guckel B, Stumm S, Rentzsch C, Marme A,
Mannhardt G and Wallwiener D: A CD80-transfected human breast
cancer cell variant induces HER-2/neu-specific T cells in
HLA-A*02-matched situations in vitro as well as in vivo. Cancer
Immunol Immunother. 54:129–140. 2005.PubMed/NCBI
|
|
12
|
Gille H, Kowalski J, Li B, et al: Analysis
of biological effects and signaling properties of Flt-1 (VEGFR-1)
and KDR (VEGFR-2). A reassessment using novel receptor-specific
vascular endothelial growth factor mutants. J Biol Chem.
276:3222–3230. 2001. View Article : Google Scholar
|
|
13
|
Zeng H, Dvorak HF and Mukhopadhyay D:
Vascular permeability factor (VPF)/vascular endothelial growth
factor (VEGF) peceptor-1 down-modulates VPF/VEGF
receptor-2-mediated endothelial cell proliferation, but not
migration, through phosphatidylinositol 3-kinase-dependent
pathways. J Biol Chem. 276:26969–26979. 2001. View Article : Google Scholar
|
|
14
|
Takahashi Y, Kitadai Y, Bucana CD, Cleary
KR and Ellis LM: Expression of vascular endothelial growth factor
and its receptor, KDR, correlates with vascularity, metastasis, and
proliferation of human colon cancer. Cancer Res. 55:3964–3968.
1995.PubMed/NCBI
|
|
15
|
Vajkoczy P, Farhadi M, Gaumann A, et al:
Microtumor growth initiates angiogenic sprouting with simultaneous
expression of VEGF, VEGF receptor-2, and angiopoietin-2. J Clin
Invest. 109:777–785. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Breier G, Blum S, Peli J, et al:
Transforming growth factor-beta and Ras regulate the
VEGF/VEGF-receptor system during tumor angiogenesis. Int J Cancer.
97:142–148. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Prewett M, Huber J, Li Y, et al:
Antivascular endothelial growth factor receptor (fetal liver kinase
1) monoclonal antibody inhibits tumor angiogenesis and growth of
several mouse and human tumors. Cancer Res. 59:5209–5218. 1999.
|
|
18
|
Wood JM, Bold G, Buchdunger E, et al:
PTK787/ZK 222584, a novel and potent inhibitor of vascular
endothelial growth factor receptor tyrosine kinases, impairs
vascular endothelial growth factor-induced responses and tumor
growth after oral administration. Cancer Res. 60:2178–2189.
2000.
|
|
19
|
Thomas AL, Morgan B, Drevs J, et al:
Vascular endothelial growth factor receptor tyrosine kinase
inhibitors: PTK787/ZK 222584. Semin Oncol. 30:32–38. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu JY, Wei YQ, Yang L, et al:
Immunotherapy of tumors with vaccine based on quail homologous
vascular endothelial growth factor receptor-2. Blood.
102:1815–1823. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li G, Tian L, Hou JM, et al: Improved
therapeutic effectiveness by combining recombinant CXC chemokine
ligand 10 with cisplatin in solid tumors. Clin Cancer Res.
11:4217–4224. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Seong SY and Matzinger P: Hydrophobicity:
an ancient damage-associated molecular pattern that initiates
innate immune responses. Nat Rev Immunol. 4:469–478. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jiang D, Liang J, Fan J, et al: Regulation
of lung injury and repair by Toll-like receptors and hyaluronan.
Nat Med. 11:1173–1179. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tsung A, Sahai R, Tanaka H, et al: The
nuclear factor HMGB1 mediates hepatic injury after murine liver
ischemia-reperfusion. J Exp Med. 201:1135–1143. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Apetoh L, Ghiringhelli F, Tesniere A, et
al: Toll-like receptor 4-dependent contribution of the immune
system to anticancer chemotherapy and radiotherapy. Nat Med.
13:1050–1059. 2007. View
Article : Google Scholar
|
|
26
|
Soliman H: Developing an effective breast
cancer vaccine. Cancer Control. 17:183–190. 2010.PubMed/NCBI
|
|
27
|
Solbrig CM, Saucier-Sawyer JK, Cody V,
Saltzman WM and Hanlon DJ: Polymer nanoparticles for immunotherapy
from encapsulated tumor-associated antigens and whole tumor cells.
Mol Pharm. 4:47–57. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu S, Wang H, Yang Z, et al: Enhancement
of cancer radiation therapy by use of adenovirus-mediated
secretable glucose-regulated protein 94/gp96 expression. Cancer
Res. 65:9126–9131. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shalaby F, Rossant J, Yamaguchi TP, et al:
Failure of blood-island formation and vasculogenesis in
Flk-1-deficient mice. Nature. 376:62–66. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wei YQ, Wang QR, Zhao X, et al:
Immunotherapy of tumors with xenogeneic endothelial cells as a
vaccine. Nat Med. 6:1160–1166. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pe'er J, Shweiki D, Itin A, Hemo I,
Gnessin H and Keshet E: Hypoxia-induced expression of vascular
endothelial growth factor by retinal cells is a common factor in
neovascularizing ocular diseases. Lab Invest. 72:638–645.
1995.PubMed/NCBI
|
|
32
|
Plate KH, Breier G, Weich HA and Risau W:
Vascular endothelial growth factor is a potential tumour
angiogenesis factor in human gliomas in vivo. Nature. 359:845–848.
1992. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Folkman J: What is the evidence that
tumors are angiogenesis dependent? J Natl Cancer Inst. 82:4–6.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fine BA, Valente PT, Feinstein GI and Dey
T: VEGF, flt-1, and KDR/flk-1 as prognostic indicators in
endometrial carcinoma. Gynecol Oncol. 76:33–39. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fidler IJ and Ellis LM: The implications
of angiogenesis for the biology and therapy of cancer metastasis.
Cell. 79:185–188. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yancopoulos GD, Klagsbrun M and Folkman J:
Vasculogenesis, angiogenesis, and growth factors: ephrins enter the
fray at the border. Cell. 93:661–664. 1998. View Article : Google Scholar : PubMed/NCBI
|
